Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults

Basit Öğe Kaydı
dc.contributor.authorGundogan, Kursat
dc.contributor.authorBayram, Fahri
dc.contributor.authorGedik, Vedia
dc.contributor.authorKaya, Ahmet
dc.contributor.authorKaraman, Ahmet
dc.contributor.authorDemir, Ozgur
dc.contributor.authorSabuncu, Tevfik
dc.date.accessioned2020-03-26T18:42:28Z
dc.date.available2020-03-26T18:42:28Z
dc.date.issued2013
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractIntroduction: The aim of this study is to investigate the prevalence of metabolic syndrome (MS) and its components according to Adult Treatment Panel III (ATP III) and International Diabetes Federation (IDF) criteria and the risk factors affecting MS. Metabolic syndrome prevalence was evaluated according to certain quintet age groups, altitude, location and demographic features. Material and methods: This study was a cross-sectional survey conducted in 24 provinces from the 7 regions of Turkey. A total of 4309 adults from 7 regions participated in the study (1947 males, 45.2%). Results: The mean age of participants was 47 +/- 14 years. Metabolic syndrome prevalence was found as 36.6% according to ATP III and 44.0% according to IDF The MS rate was found to be higher in females compared to males in both groups (p < 0.01). According to both criteria, MS prevalence was found to be higher in subjects who lived in coastal regions when evaluated according to altitude and in subjects who lived in district centers when evaluated according to location. The MS risk is 1.62-fold higher in females compared to males. Metabolic syndrome risk increases as age increases and is highest in the 61-65 age group. Metabolic syndrome risk increases 2.75-fold in the overweight compared to normal weighing subjects and 7.80-fold in the obese. Conclusions: Metabolic syndrome prevalence was found to be high in Turkey according to both criteria. Metabolic syndrome prevalence increases as age and body mass index (BMI) increase. Age, female gender and obesity are independent risk factors for MS development.en_US
dc.identifier.doi10.5114/aoms.2013.34560en_US
dc.identifier.endpage253en_US
dc.identifier.issn1734-1922en_US
dc.identifier.issn1896-9151en_US
dc.identifier.issue2en_US
dc.identifier.pmid23671434en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage243en_US
dc.identifier.urihttps://dx.doi.org/10.5114/aoms.2013.34560
dc.identifier.urihttps://hdl.handle.net/20.500.12395/29638
dc.identifier.volume9en_US
dc.identifier.wosWOS:000317994900007en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTERMEDIA PUBLISHING HOUSE LTDen_US
dc.relation.ispartofARCHIVES OF MEDICAL SCIENCEen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectmetabolic syndromeen_US
dc.subjectaltitudeen_US
dc.subjectage groupsen_US
dc.titleMetabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adultsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu